These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30207064)

  • 1. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.
    Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27454. PubMed ID: 30207064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan.
    Shioda Y; Adachi S; Imashuku S; Kudo K; Imamura T; Morimoto A
    Int J Hematol; 2011 Dec; 94(6):545-51. PubMed ID: 22139588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis.
    Nakagawa S; Shinkoda Y; Hazeki D; Imamura M; Okamoto Y; Kawakami K; Kawano Y
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):873-8. PubMed ID: 27089406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis.
    Lian H; Cui L; Yang Y; Wei A; Cheng H; Li N; Zhang L; Ma H; Zhao X; Wang T; Li Z; Zhang R
    Pituitary; 2022 Feb; 25(1):108-115. PubMed ID: 34302575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapses of multisystem/multifocal bone Langerhans cell histiocytosis in paediatric patients: Data analysis from the JLSG-96/02 study.
    Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
    Br J Haematol; 2023 Mar; 200(6):769-775. PubMed ID: 36511451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
    Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
    Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
    Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kawaguchi H; Sakashita K; Yasui M; Koga Y; Kobayashi R; Ishii E; Fujimoto J; Horibe K; Bessho F; Tsunematsu Y; Imashuku S
    Int J Hematol; 2016 Jul; 104(1):99-109. PubMed ID: 27040279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thickening of the pituitary stalk in children and adolescents with central diabetes insipidus: Causes and consequences].
    Corredor Andrés B; Muñoz Calvo MT; López Pino MÁ; Márquez Rivera M; Travieso Suárez L; Pozo Román J; Argente J
    An Pediatr (Engl Ed); 2019 May; 90(5):293-300. PubMed ID: 29895434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.
    Prosch H; Grois N; Prayer D; Waldhauser F; Steiner M; Minkov M; Gadner H
    Pediatr Blood Cancer; 2004 Oct; 43(5):594-9. PubMed ID: 15382278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
    Huang JB; Xue HM; Chen YY; Huang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China.
    Ji X; Wang Z; Wang W; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Front Endocrinol (Lausanne); 2020; 11():76. PubMed ID: 32153511
    [No Abstract]   [Full Text] [Related]  

  • 14. Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall.
    Prosch H; Grois N; Bökkerink J; Prayer D; Leuschner I; Minkov M; Gadner H
    Pediatr Blood Cancer; 2006 Mar; 46(3):363-6. PubMed ID: 15942956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome Comparison of Pediatric Langerhans Cell Histiocytosis Treated with Modified DAL-HX83/90 or JLSG-96 Protocol].
    Huang JB; Jiang L; Chen C; Xue HM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1190-5. PubMed ID: 27531798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.
    Vaiani E; Felizzia G; Lubieniecki F; Braier J; Belgorosky A
    Horm Res Paediatr; 2021; 94(1-2):9-17. PubMed ID: 34167121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies.
    Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
    Br J Haematol; 2021 Feb; 192(3):615-620. PubMed ID: 33236384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
    Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
    Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central diabetes insipidus: clinical profile that suggests organicity in Peruvian children: Lima - Peru 2001-2013.
    De Los Santos MA; Águila CM; Rojas MI; Falen JM; Nuñez O; Chávez EM; Espinoza OA; Pinto PM; Calagua MR
    J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1353-1358. PubMed ID: 27845884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.